Swapnroop Drugs & Pharmac...

Amodiaquine Base is a vital antimalarial Active Pharmaceutical Ingredient (API) manufactured with precision and care by Swapnroop Drugs & Pharmaceuticals. As a trusted manufacturer and exporter, Swapnroop ensures that the product meets international quality standards.

Uses: Amodiaquine is widely used in the treatment and prevention of malaria, especially in regions where resistance to other antimalarials is a concern. It is commonly included in combination therapies with artesunate.

Why Choose Swapnroop Drugs & Pharmaceuticals?

• GMP-Compliant manufacturing
• Stringent quality testing
• Global export capabilities
• Commitment to life-saving therapeutics

This API plays a crucial role in saving lives in malaria-prone countries. Through continuous innovation and strict compliance, Swapnroop contributes to global healthcare advancement.

Acebutolol Hydrochloride (HCl) is a cardioselective beta-1 adrenergic blocker with intrinsic sympathomimetic activity (ISA), widely used in cardiovascular therapeutics. As a leading manufacturer and global supplier, Swapnroop Drugs & Pharmaceuticals produces high-purity Acebutolol HCl API that complies with USP, EP, BP, and ICH standards, ensuring efficacy and safety in pharmaceutical formulations

Acebutolol HCl is a cardioselective beta-1 adrenergic receptor blocker with mild intrinsic sympathomimetic activity. It is used primarily in the treatment of hypertension (high blood pressure) and cardiac arrhythmias (irregular heartbeats). Its selective action makes it particularly suitable for patients who are sensitive to the side effects of non-selective beta blockers.

Molecular Formula: C18H28ClNO4

Molecular Weight: 357.87 g/mol

Drug Class: Beta-1 Selective Adrenergic Receptor Antagonist (Cardioselective Beta Blocker)

Medical Uses of Acebutolol HCl

1. Hypertension (High Blood Pressure)

Acebutolol helps reduce blood pressure by slowing the heart rate and reducing the force of contraction. By inhibiting beta-1 receptors in the heart, it decreases cardiac output and thus lowers blood pressure levels over time. It is often used as monotherapy or in combination with other antihypertensive agents like diuretics or calcium channel blockers.

Amisulpride API manufactured by Swapnroop Drugs & Pharmaceuticals is a high-purity active pharmaceutical ingredient (API) used primarily in the treatment of various mental health conditions, particularly schizophrenia and acute psychotic episodes.

Key Details:

•  Therapeutic Class: Atypical antipsychotic
• Mechanism of Action: Acts as a selective dopamine D/D receptor antagonist, helping to restore the balance of neurotransmitters in the brain.
• Form: High-quality, bulk API (Active Pharmaceutical Ingredient) suitable for formulation into tablets or injectable medications.
• Certifications:
• WHO-GMP Certified
• ISO Certified Manufacturing Facility
• Use Cases:
• Schizophrenia (positive and negative symptoms)
• Dysthymia and other depressive disorders (off-label in some regions)

Swapnroop’s API ensures consistency, regulatory compliance, and is suitable for export to regulated markets globally.

Would you like a product brochure or detailed technical specification sheet (TDS/MSDS) for this API?

What is  Amisulpride API Manufactured by Swapnroop Drugs and Pharmaceuticals used for?

Therapeutic Applications of Amisulpride API

Manufactured by Swapnroop Drugs & Pharmaceuticals (WHO-GMP & ISO 9001:2015 Certified)

Amisulpride API is a selective dopamine D2/D3 receptor antagonist classified as an atypical antipsychotic. It is primarily used to treat psychiatric disorders due to its unique limbic system specificity. Below are its key therapeutic uses, supported by clinical and regulatory data:

1. Approved Indications

A. Schizophrenia

• Target Symptoms:
• Positive Symptoms: Hallucinations, delusions, thought disorders.
• Negative Symptoms: Social withdrawal, emotional blunting, anhedonia.
• Dosage Range:
• 400–800 mg/day (split doses for doses >400 mg).
• Low doses (50–300 mg/day) preferentially improve negative symptoms.

B. Acute Psychotic Episodes

• Rapid Action: Reduces agitation and aggression within 3–7 days.
• IM Formulation: Used in hospital settings for acute control.

2. Off-Label Uses (Clinically Supported)

A. Dysthymia & Depression

• Mechanism: Dopamine modulation in mesolimbic pathways.
• Dose: 50 mg/day (significantly lower than antipsychotic doses).

Swapnroop Drugs & Pharmaceuticals is aWHO-GMP & ISO-certified manufacturerof high-qualityAcamprosate Calcium API, a critical therapeutic agent used in the treatment ofalcohol dependence. Our state-of-the-art facility inMaharashtra, India, ensures>99.5% purity, strict regulatory compliance, and reliable global supply.

Acamprosate Calcium is a well-recognized pharmaceutical compound used in the treatment of alcohol dependence. It is not meant to treat withdrawal symptoms or to be used as a detox agent. Rather, it supports individuals who have already stopped drinking, helping to maintain abstinence and reduce cravings, which significantly lowers the chances of relapse.

This API works by restoring the chemical balance in the brain that is disrupted due to chronic alcohol use. It primarily modulates glutamatergic neurotransmission, bringing equilibrium between neuronal excitation and inhibition a balance often distorted in individuals with alcohol use disorders.

Manufactured with Precision: Swapnroop Drugs and Pharmaceuticals

The quality and consistency of APIs are critical to the efficacy and safety of the final pharmaceutical product. Thats where Swapnroop Drugs and Pharmaceuticals comes in. With years of experience and a commitment to pharmaceutical excellence, Swapnroop has emerged as a trusted manufacturer and global exporter of high-quality Acamprosate Calcium API.

ARTEETHER APIis a semi-synthetic derivative of artemisinin, derived from the plantArtemisia annua, and is primarily used for treating severe and chloroquine-resistantPlasmodium falciparummalaria, including cerebral malaria

Swapnroop Drugs & Pharmaceuticals, established in 2013 and based in Aurangabad, Maharashtra, is an ISO 9001:2008 and FDA-approved pharmaceutical company.They specialize in the sales and marketing of Active Pharmaceutical Ingredients (APIs), intermediates, herbal extracts, and pharmaceutical formulations.Their product portfolio includes over 500 molecules catering to various therapeutic areas such as anti-infectives, cardiovascular, CNS, gastrointestinal, and more

Acebrophyllineis aunique bronchodilator + mucolyticAPI that revolutionizes respiratory therapy. Swapnroop manufactureshigh-purity, GMP-certified Acebrophylline APIwith stringent quality control. Here 's everything you need to know:

Acebrophyllineis adual-action respiratory drugcombiningbronchodilator + mucolytic properties. Swapnroop 's GMP-certified API is used to formulate medications for chronic respiratory conditions. Heres a detailed breakdown of its uses:

• Action:

  • Relaxes bronchial muscles (viatheophyllinederivative) improves airflow.

  • Thickens & clears mucus (viaambroxolmetabolite) reduces cough.

• Formulations:

  • Sustained-release tablets (100-200mg).

  • Fixed-dose combinations withterbutaline.

• Action:

  • Reduces airway hyperresponsiveness.

  • Prevents mucus plug formation in acute attacks.

• Pediatric Use: Often formulated assyrups (50mg/5ml)for children.

• Action:

  • Breaks downacidic mucopolysaccharidesin mucus.

  • Reduces exacerbation frequency.

Aceclofenac is anon-steroidal anti-inflammatory drug (NSAID)used to relieve pain and inflammation in conditions likearthritis, rheumatoid arthritis, osteoarthritis, and musculoskeletal disorders. Swapnroop Drugs & Pharmaceuticals specializes in the high-quality production ofAceclofenac Active Pharmaceutical Ingredient (API), ensuring compliance with global pharmacopeial standards (USP, BP, EP).

dexmethylphenidate hydrochloride is acentral nervous system (cns) stimulantprimarily used for the treatment ofattention deficit hyperactivity disorder (adhd)andnarcolepsy. It is thed-threo-enantiomerofmethylphenidate, making it a more pharmacologically active version of the parent compound. Manufactured byswapnroop drugs & pharmaceuticals, this api (active pharmaceutical ingredient) is developed under strict gmp guidelines to ensure itspurity, potency, andsafetyfor pharmaceutical formulations.

Dexmethylphenidatemanufactured bySwapnroop Drugs & Pharmaceuticalsis a high-quality pharmaceutical active ingredient used primarily in the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy.

Bilastineis a second-generation, non-sedatingantihistamine used primarily to relieve symptoms ofallergic rhinitis(seasonal allergies) andchronic urticaria(hives). Swapnroop Drugs & Pharmaceuticals manufactures Bilastine as anActive Pharmaceutical Ingredient (API)for use in various dosage forms like tablets and syrups.

Dabigatran Etexilate Mesylateis the mesylate salt form of dabigatran etexilate aprodrugofdabigatran, which is adirect thrombin inhibitor. It is anoral anticoagulant(blood thinner) used to prevent and treat blood clots and reduce the risk of stroke, especially in patients withnon-valvular atrial fibrillation.

Swapnroop Drugs & Pharmaceuticals is an Indian pharmaceutical manufacturer that producesActive Pharmaceutical Ingredients (APIs)including Dabigatran Etexilate Mesylate. As an API supplier, they provide this compound to companies that formulate it intocapsules, which is the standard dosage form.

Clozapine is atricyclic dibenzodiazepine derivativethat selectively targets neurotransmitters in the brain. It is classified as anatypical (second-generation) antipsychoticand is primarily used for:

• Treatment-resistantschizophrenia

• Reducing the risk ofsuicidal behaviorin schizophrenic patients

Unlike typical antipsychotics, Clozapineexhibitsminimal extrapyramidal side effects, making it unique but also requiring special monitoring due to itsrisk of agranulocytosis(a potentially dangerous drop in white blood cells).

Dextromethorphan Baseis a synthetic, non-opioidcough suppressant (antitussive), belonging to the morphinan class of medications. It is commonly used in over-the-counter (OTC) medications to helprelieve dry, irritating coughsthat do not produce mucus.

TheDEXTROMETHORPHAN BASEmanufactured bySwapnroop Drugs & Pharmaceuticalsis a pharmaceutical-grade active pharmaceutical ingredient (API) that meets stringent quality standards for use informulating oral solid, liquid, and lozenge dosage forms.

• CAS Number: 58-32-2

• Molecular Formula: CHNO

• Molecular Weight: 504.63 g/mol

• Synonyms: Persantine, Dipyridamol, Dipyridamine, Dipyudamine

• Mechanism of Action: Dipyridamole acts as a phosphodiesterase inhibitor and adenosine reuptake inhibitor, leading to increased levels of cyclic AMP and adenosine. This results in inhibition of platelet

• CAS Number: 624-49-7

• Molecular Formula: CHO

• Molecular Weight: 144.13 g/mol

• Synonyms: DMF, BG-12, Tecfidera (brand name for oral use in MS)

• Appearance: White to off-white crystalline powder

• Mechanism of Action: Activates the Nrf2 pathway, offering anti-inflammatory and cytoprotective effects, and modulating immune responses.

• CAS Number: 71939-50-9

• Molecular Formula: CHO

• Molecular Weight: 284.35 g/mol

• Synonyms: DHA, Dihydroqinghaosu

• Mechanism of Action: Acts via production of free radicals in the presence of iron inside the Plasmodium parasite, causing oxidative damage and death of the parasite.

• Class: Artemisinin derivative (sesquiterpene lactone with a peroxide bridge)

• CAS Number: 22494-42-4

• Molecular Formula: CHFO

• Molecular Weight: 250.20 g/mol

• Chemical Structure: A difluorinated derivative of salicylic acid

• Mechanism of Action: Inhibits cyclooxygenase (COX-1 and COX-2), leading to reduced synthesis of prostaglandins responsible for pain and inflammation

• CAS Number: 15307-79-6

• Molecular Formula: CHClNNaO

• Molecular Weight: 318.13 g/mol

• Class: NSAID, Phenylacetic acid derivative

• Mechanism of Action: Inhibits cyclooxygenase (COX-1 and COX-2) enzymes, reducing prostaglandin synthesis involved in pain, inflammation, and fever